课题基金 / 基金详情

Cancer Prevention and Control Program

Cancer Prevention and Control Program
癌症预防和控制计划
批准号:
10671702
负责人:
Edward F. Ellerbeck
金额:
$3.95万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-07-11 至 2027-06-30
关键词:
AddressAdvocacyAffectAfrican AmericanAmerican IndiansAreaAwardBehaviorBehavioralBehavioral SciencesBiological MarkersBiologyBiometryBreastCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCancer Control ResearchCancer Control Research ProgramCancer PatientCancer SurvivorshipCaringCatchment AreaClinicalCollaborationsCommunicationCommunitiesCommunity OutreachCommunity PracticeCriminal JusticeData ScienceDetectionDevelopmentDiagnosisDiscipline of NursingDiseaseDisease MarkerDisease ProgressionEconomicsEnsureEpidemiologyEquityEvidence based interventionExclusionExtramural ActivitiesFacultyFosteringFundingGrantGuidelinesHealth Services ResearchHereditary Malignant NeoplasmHispanicImmunizationIncidenceIndividualInfrastructureInterventionIntervention StudiesKansasLesionLongevityMalignant NeoplasmsMentorshipMethodsMissionModelingMolecularMorbidity - disease rateNational Cancer InstituteNeurosciencesNutritionalObesityObservational StudyOncologyPain managementPathway interactionsPatientsPersonsPharmacologyPhasePhysical activityPilot ProjectsPoliciesPopulationPopulation SciencesPopulations at RiskPositioning AttributePragmatic clinical trialPreventionPrimary Cancer PreventionPrimary CarePrimary PreventionPrincipal InvestigatorProductivityProviderPublic HealthPublishingRecurrent Malignant NeoplasmResearchResearch DesignResearch PersonnelResearch Project GrantsRiskRisk FactorsRuralRural CommunityRural MinorityScholars ProgramSchoolsScientific Advances and AccomplishmentsScreening for cancerServicesSmokingSystemTestingTrainingTranslatingTranslational ResearchTranslationsUniversitiesWorkWritinganticancer researchbehavioral clinical trialbiomarker drivenbiomarker identificationcancer biomarkerscancer carecancer complicationcancer health disparitycancer preventioncancer recurrencecancer riskcancer therapycare deliveryclinical practicecommunity engagementdesigneffective interventionevidence basegastrointestinalhereditary riskhigh riskhigh risk populationimplementation scienceimprovedinnovationmemberminority communitiesmultidisciplinaryneighborhood disadvantagenovelnutritionpharmacologicphysical inactivitypopulation healthpractice settingpragmatic studypragmatic trialpremalignantpreventprogramsstudent mentoringsuccesssupport networksurvivorshiptelehealthtobacco controltranslational pipelineunderserved minorityvisiting scholarworking group

项目摘要

项目成果

Edward F. Ellerbeck的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CANCER PREVENTION AND CONTROL: ABSTRACT The Cancer Prevention and Control (CPC) research program at The University of Kansas Cancer Center (KUCC) brings together an interdisciplinary team of researchers focused on: 1) developing, testing, and implementing innovative strategies to modify behaviors that drive cancer risk and disparities in cancer incidence (Population-Level Primary Prevention); 2) identifying biomarker-driven opportunities for cancer prevention among high-risk individuals with premalignant disease or hereditary cancer risk and testing interventions to improve detection and modulation of risk biomarkers associated with cancer prevention in these high-risk patients (High-Risk Prevention); and 3) developing and disseminating behavioral, nutritional, and clinical support interventions to address the impact of cancer (Survivorship). The 49 members of CPC come from 23 departments in six schools. They represent a rich mix of expertise, including behavioral science, neuroscience, primary care, nursing, oncology, epidemiology, economics, translational biology, pharmacology, communications, biostatistics, and health services research. Program members are supported by $13.3M in total annual funds, including $3.8M from the National Cancer Institute. Currently, 69% of CPC members are principal investigators on externally funded cancer research grants. CPC program activities support both intra- and inter-programmatic interactions through translational research seminars, a visiting scholar program, and cancer care delivery and equity, tobacco control, implementation science, and health services research working groups. These activities have fostered intra- and inter-programmatic productivity, resulting in 225 articles published by CPC members in 2020, of which 20% had inter-programmatic, 32% had intra- programmatic, and 67% had external collaborations. The work in CPC begins and ends with the needs of the KUCC catchment area. CPC members have shown remarkable success in developing the infrastructure to conduct cancer prevention and control research in our region among rural, African American, Hispanic, and American Indian communities and individuals in the criminal justice system. A strong mentorship program places a significant focus on training. Seven CPC trainees received more than $1.2M in extramural training grant support in 2020 alone; CPC members have demonstrated a 9.2-fold return from CCSG Developmental Funds and a 23.3-fold return from KUCC Pilot Projects. The shared work of CPC members has led to: a better understanding of the cancer control needs in the KUCC catchment area; improved capacity to analyze the needs of affected and at-risk populations; identification of novel pre-cancerous models and new biomarkers; improved strategies to detect and prevent cancer in high-risk patients; better strategies for the design and delivery of cancer prevention and control messages; and improved delivery of tobacco control, cancer screening, physical activity, obesity, and survivorship programs at the level of both the clinical practice and the community-at-large.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Implementation Science and Equity: Pragmatic Implementation Science Methods (PrISM) Core
Frontiers: University of Kansas Clinical and Translational Science Institute
Frontiers: University of Kansas Clinical and Translational Science Institute
Institutional Career Development Core
海外基金